​The panel discussion at this evening’s MAPS APAC Summit continued discussing “An integrated approach to evidence generation”. The key points made were:

  • An integrated approach holistically identifies and prioritizes evidence needs for all stakeholders for a given asset across its life cycle.

  • It is backed by a formal process to keep it complete and up-to-date, as well as consistent in framework and depth across all assets.

  • It builds an integrated cross-functional work plan to strategically and efficiently fill high priority evidence gaps.

  • And it increases transparency by cataloguing past and ongoing data generation across functions.

 

An integrated evidence planning process involves:

  • Convening an Integrated Evidence Planning team.

  • Developing strategic context

  • Assembling evidence catalogues

  • Ideating on evidence gaps

  • Prioritising evidence gaps across functions.

  • Aligning plans to fill priority evidence gaps

  • Gathering and integrating input from additional stakeholders

  • Garnering sign-off and then executing

  • Ensuring living document through updates.

 

 

Thanks to the panellists:

Alan McDougall, VP Medical Affairs International Markets
Greater China Astellas

Marie Hartley, Director Medical Affairs Sandoz

Brian Bradbury, VP Center for Observational Research Amgen

Jan van Overbeeke, Partner McKinsey & Company

Shuhei Fujita, Vice President Medical Science Astellas

Gemma Zhu, Senior Director Clinical and Outcomes Research Bayer

 

 

HPG (Healthcare Professionals Group)

www.hpgconnect.com

Sydney (02) 8877 8777

Melbourne (03) 9938 7100

#MedicalAffairs #MSL #drugdevelopment #pharmaceuticals #biotechnology